2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2018-4-1-39-521374GeneticsTHE ROLE OF POLYMORPHISMS OF GLUTAMATE-CYSTEINE LIGASE IN TYPE 2 DIABETES MELLITUS SUSCEPTIBILITY IN KURSK POPULATIONTHE ROLE OF POLYMORPHISMS OF GLUTAMATE-CYSTEINE LIGASE IN TYPE 2 DIABETES MELLITUS SUSCEPTIBILITY IN KURSK POPULATIONAzarovaIuliia E.AzarovaIuliia E.azzzzar@yandex.ruKlyosovaElena Yu.KlyosovaElena Yu.ecless@yandex.ruKonoplyaAlexandr I.KonoplyaAlexandr I.20184100

Relevance. Glutamate-cysteine ligase (GCL) is the first enzyme of the glutathione cycle, intra- and extracellular antioxidant, whose impaired metabolism plays an important role in type 2 diabetes (T2D) pathogenesis. Problem. The authors study associations of the GCLC (-129 C>T, rs17883901) and GCLM (-588 C>T, rs41303970) polymorphisms with the risk of T2D development and pro/antioxidant status in the population of Kursk region. Materials and methods. The study groups included 700 T2D patients (269 males and 431 females) of mean age 59,24±8,77 who were admitted to the endocrinological department of Kursk Emergency Hospital from November 2015 to May 2017, and 718 healthy subjects (311 males and 407 females) of mean age 58,61±7,65. Genotyping of GCLC (-129 C>T, rs17883901) and GCLM (-588 C>T, rs41303970) polymorphisms was performed by PDAF, PCR, real-time discrimination of alleles using TaqMan probes. Statistical analysis was performed with the use of the on-line software SNPStats. Results. There was no difference in genotype distribution among type 2 DM and control subjects in GCLC and GCLM genes (р>0,05). Sex-stratified analysis revealed association of T/T genotype of GCLC gene with an increased risk of T2D development exclusively in males (OR 1,65, 95%CI 1,05-2,61, p=0,03) and particularly in a subgroup of smokers (OR 2,36, 95%CI 1,19-4,65, p=0,01); they also showed an increased frequency of rare allele T of GCLC gene (OR 1,69, 95%CI 1,11-2,58, p=0,02), and elevated plasma levels of oxidized glutathione GSSG and hydrogen peroxide. Conclusions. Smoking and rare allele T of the GCLC gene (rs17883901) increase susceptibility to T2D in males and contribute to formation of imbalance in pro- and antioxidant systems.

Relevance. Glutamate-cysteine ligase (GCL) is the first enzyme of the glutathione cycle, intra- and extracellular antioxidant, whose impaired metabolism plays an important role in type 2 diabetes (T2D) pathogenesis. Problem. The authors study associations of the GCLC (-129 C>T, rs17883901) and GCLM (-588 C>T, rs41303970) polymorphisms with the risk of T2D development and pro/antioxidant status in the population of Kursk region. Materials and methods. The study groups included 700 T2D patients (269 males and 431 females) of mean age 59,24±8,77 who were admitted to the endocrinological department of Kursk Emergency Hospital from November 2015 to May 2017, and 718 healthy subjects (311 males and 407 females) of mean age 58,61±7,65. Genotyping of GCLC (-129 C>T, rs17883901) and GCLM (-588 C>T, rs41303970) polymorphisms was performed by PDAF, PCR, real-time discrimination of alleles using TaqMan probes. Statistical analysis was performed with the use of the on-line software SNPStats. Results. There was no difference in genotype distribution among type 2 DM and control subjects in GCLC and GCLM genes (р>0,05). Sex-stratified analysis revealed association of T/T genotype of GCLC gene with an increased risk of T2D development exclusively in males (OR 1,65, 95%CI 1,05-2,61, p=0,03) and particularly in a subgroup of smokers (OR 2,36, 95%CI 1,19-4,65, p=0,01); they also showed an increased frequency of rare allele T of GCLC gene (OR 1,69, 95%CI 1,11-2,58, p=0,02), and elevated plasma levels of oxidized glutathione GSSG and hydrogen peroxide. Conclusions. Smoking and rare allele T of the GCLC gene (rs17883901) increase susceptibility to T2D in males and contribute to formation of imbalance in pro- and antioxidant systems.

type 2 diabetes mellitussingle nucleotide polymorphismGCLCGCLMgenetic predispositiontype 2 diabetes mellitussingle nucleotide polymorphismGCLCGCLMgenetic predispositionСписок литературыAmetov, A.S., Solovieva, O.L. (2011), “Okislitel'niy stress pri sakharnom diabete 2-go tipa i puti yego korrektsii” [Oxidative stress in type 2 diabetes mellitus and ways of its correction], Problemy endokrinologii, 57(6), 52-56. Russian.Dedov, I.I., Shestakova, M.V., Galstyan, G.R. (2016), “Rasprostranennost' sakharnogo diabeta 2 tipa u vzroslogo naseleniya Rossii (issledovaniye NATION)” [The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study)], Sakharnyy diabet, 19(2), 104-112. Russian.Dedov, I.I., Shestakova, M.V., Ametov, A.S., Antsiferov, M.B., Galstyan, G.R., Mayorov, A.Yu., Mkrtumyan, A.M., Petunina, N.A., Sukhareva, O.Yu. (2015), “Initsiatsiya i intensifikatsiya sakharosnizhayushchey terapii u bol'nykh sakharnym diabetom 2 tipa: obnovleniye konsensusa soveta ekspertov Rossiyskoy assotsiatsii endokrinologov (2015 g.)” [Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of the Russian Association of Endocrinologists expert consensus document (2015)], Sakharnyy diabet, 18(1), 5-23. Russian.Alberti, K.G.M.M., Zimmet, P.F. (1998), “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation”, Diabetic medicine, 15(7), 539-553.American Diabetes Association. Smoking and diabetes, Diabetes Care. (2003), 26(1), 89-91.Benjamini, Y., Hochberg, Y. (1995), “Controlling the false discovery rate: a practical and powerful approach to multiple testing”, Journal of the royal statistical society. Series B (Methodological), 289-300.Chang, Y.C., Chuang, L.M. (2010) “The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to Clinical implication”, Am J Transl Res, 2(3), 316-331.Guo, S., Dai, C., Guo M. (2013), “Inactivation of specific в cell transcription factors in type 2 diabetes”, The Journal of clinical investigation, 123(8), 3305-3316.Hanzawa, R., Ohnuma, T., Nagai, Y., Shibata, N., Maeshima, H., Baba, H., Arai, H. (2011), “No association between glutathione‐synthesis‐related genes and Japanese schizophrenia”, Psychiatry and clinical neurosciences, 65(1), 39-46.Harmon, J.S., Stein, R., Robertson, R.P. (2005), “Oxidative stress-mediated, post- translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells”, J Biol Chem, 280, 11107-11113.Hashemi, M., Hoseini, H., Yaghmaei, P., Moazeni-Roodi, A., Bahari, A., Hashemzehi, N., Shafieipour, S. (2011), “Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease”, DNA and cell biology, 30(8), 569-575.International Diabetes Federation. IDF Diabetes Atlas 8th Edition (2017). Brussels: Belgium. idf.org, 1-4.Koide, S.I., Kugiyama, K., Sugiyama, S., Nakamura, S.I., Fukushima, H., Honda, O., Ogawa, H. (2003), “Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction”, Journal of the American College of Cardiology, 41(4), 539-545.Maniatis T. (1982), “Molecular cloning”, A Laboratory Manual.Nakamura, S.I., Kugiyama, K., Sugiyama, S., Miyamoto, S., Koide, S.I., Fukushima, H., Ogawa, H. (2002), “Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction”, Circulation, 105(25), 2968-2973.Nourooz-Zadeh , J., Tajaddini-Sarmadi, J., McCarthy, S., Betteridge, D.J., Wolff, S.P. (1995), “Elevated levels of authentic plasma hydroperoxides in NIDDM”, Diabetes, 44, 1054-1058.Palit, S., Kar, S., Sharma, G., Das, P.K. (2015), “Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ROS and activation of ASK1/JNK pathway”, Journal of cellular physiology, 230(8), 1729-1739.Pan, A., Wang, Y., Talaei, M., Hu, F.B., Wu, T. (2015), “Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis”, The lancet Diabetes & endocrinology, 3(12), 958-967.Shiizaki, S., Naguro, I., Ichijo, H. (2013), “Activation mechanisms of ASK1 in response to various stresses and its significance in intracellular signaling”, Advances in biological regulation, 53(1), 135-144.Tiedge, M., Lortz, S., Drinkgern, J. (1997), “Relation between antioxidant enzyme gene expression and antioxidant defense status of insulin-producing cells”, Diabetes. 46(11), 1733-1742.Watanabe, T., Sekine, S., Naguro, I., Sekine, Y., Ichijo, H. (2015), “Apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway-dependent cytoplasmic translocation of the orphan nuclear receptor NR4A2 is required for oxidative stress-induced necrosis”, Journal of Biological Chemistry, 290(17), 10791-10803.Wright, E., Scism-Bacon, J.L., Glass, L.C. (2006), “Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia”, Int. J. Clin. Pract, 60(3), 308-314.Yoshida, K., Hirokawa, J., Tagami, S., Kawakami, Y., Urata, Y., Kondo, T. (1995), “Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux”, Diabetologia, 38, 201-210.